ATRIANCE 5mg/ml solution for infusion EUROPHARM ORIGINAL MEDICINE
Chemical substance: nelarabine
ATC code: L01BB07 • Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues
Active substance
Results for the substance nelarabine
1 result
About this active substance
Nelarabine is a chemotherapy drug used to treat certain types of leukemia and lymphoma, particularly T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. It belongs to a class of drugs called antimetabolites, which interfere with the growth and division of cancer cells.
Nelarabine is usually administered via intravenous infusion under the strict supervision of a specialist doctor. The treatment may be associated with significant side effects, including fatigue, nausea, vomiting, decreased blood cell counts, and an increased risk of infections.
Patients need to be closely monitored during treatment to detect any complications and adjust the dose if necessary. It is important to report any unusual symptoms, such as fever, severe pain, or signs of infection, immediately.
Since nelarabine can negatively affect the nervous system, patients may experience neurological symptoms such as numbness, weakness, or confusion. The doctor will evaluate the benefits and risks of the treatment before recommending its use.
Nelarabine is usually administered via intravenous infusion under the strict supervision of a specialist doctor. The treatment may be associated with significant side effects, including fatigue, nausea, vomiting, decreased blood cell counts, and an increased risk of infections.
Patients need to be closely monitored during treatment to detect any complications and adjust the dose if necessary. It is important to report any unusual symptoms, such as fever, severe pain, or signs of infection, immediately.
Since nelarabine can negatively affect the nervous system, patients may experience neurological symptoms such as numbness, weakness, or confusion. The doctor will evaluate the benefits and risks of the treatment before recommending its use.